These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2407103)

  • 1. Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group.
    Asbury RF; Blessing JA; McGuire WP; Hanjani P; Mortel R
    Am J Clin Oncol; 1990 Feb; 13(1):39-41. PubMed ID: 2407103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group.
    Asbury RF; Blessing JA; DiSaia PJ; Malfetano J
    Am J Clin Oncol; 1989 Oct; 12(5):375-7. PubMed ID: 2801597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
    Asbury RF; Blessing JA; Mortel R; Homesley HD; Malfetano J
    Am J Clin Oncol; 1987 Aug; 10(4):299-301. PubMed ID: 3618541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group.
    Asbury RF; Wilson J; Blessing JA; Buchsbaum HJ; DiSaia PJ
    Am J Clin Oncol; 1986 Aug; 9(4):334-6. PubMed ID: 3751971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminothiadiazole in the treatment of advanced leiomyosarcoma of the uterine corpus. A Gynecologic Oncology Group study.
    Asbury R; Blessing JA; Smith DM; Carson LF
    Am J Clin Oncol; 1995 Oct; 18(5):397-9. PubMed ID: 7572755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a Gynecologic Oncology Group study.
    Asbury R; Blessing JA; Moore D
    Am J Clin Oncol; 1996 Aug; 19(4):400-2. PubMed ID: 8677914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology Group.
    Asbury RF; Kramar A; Haller DG
    Am J Clin Oncol; 1987 Oct; 10(5):380-2. PubMed ID: 3661489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial.
    Locker GY; Kilton L; Khandekar JD; Lad TE; Knop RH; Albain K; Blough R; French S; Benson AB
    Invest New Drugs; 1994; 12(4):299-301. PubMed ID: 7775130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.
    Elson PJ; Kvols LK; Vogl SE; Glover DJ; Hahn RG; Trump DL; Carbone PP; Earle JD; Davis TE
    Invest New Drugs; 1988 Jun; 6(2):97-103. PubMed ID: 3170135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of aminothiadiazole in advanced squamous cell carcinoma of the esophagus.
    Engstrom PF; Ryan LM; Falkson G; Haller DG
    Am J Clin Oncol; 1991 Feb; 14(1):33-5. PubMed ID: 1987735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Hatch KD; Soper JT; Webster KD; Kemp GM
    Am J Clin Oncol; 1990 Feb; 13(1):61-3. PubMed ID: 2407104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group Study.
    Malfetano JH; Blessing JA; Adelson MD
    Am J Clin Oncol; 1991 Aug; 14(4):349-51. PubMed ID: 1862766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
    Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICRF-159 (razoxane) in patients with advanced adenocarcinoma of the endometrium. A Gynecologic Oncology Group Study.
    Homesley HD; Blessing JA; Conroy J; Hatch K; DiSaia PJ; Twiggs LB
    Am J Clin Oncol; 1986 Feb; 9(1):15-7. PubMed ID: 3953488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Homesley H; Creasman WT; Sutton G
    Gynecol Oncol; 1989 Apr; 33(1):68-70. PubMed ID: 2703169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminothiadiazole: an antineoplastic thiadiazole.
    O'Dwyer PJ; Wagner BH; Stewart JA; Leyland-Jones B
    Cancer Treat Rep; 1986 Jul; 70(7):885-9. PubMed ID: 2872957
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Malfetano JH; Blessing JA; Homesley HD
    Am J Clin Oncol; 1995 Dec; 18(6):495-7. PubMed ID: 8526192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma.
    Thigpen T; Vance RB; Balducci L; Blessing J
    Cancer; 1981 Jul; 48(2 Suppl):658-65. PubMed ID: 7023669
    [No Abstract]   [Full Text] [Related]  

  • 19. Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
    Thigpen JT; Blessing JA; Ball H; Hanjani P; Manetta A; Homesley H
    Gynecol Oncol; 1988 Nov; 31(3):435-8. PubMed ID: 3141250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
    Jacobs AJ; Blessing JA; Munoz A
    Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.